We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Open Label Extension Study of STX209 (Arbaclofen) in Autism Spectrum Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01706523
Recruitment Status : Terminated
First Posted : October 15, 2012
Last Update Posted : July 31, 2013
Information provided by (Responsible Party):
Seaside Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : July 2013
  Estimated Study Completion Date : July 2013